Keywords: sepracor, phase, clinical, trials, -fluoxetine, start, announced

Sepracor Phase I clinical trials of (R)-fluoxetine start

Article | 15 October 1998

Print This

Sepracor has announced that Phase I clinical trials of(R)-fluoxetine, a single isomer of racemic fluoxetine, have commenced. Racemic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in